Form 4: Ardelvx Inc. Executive Laura A. Williams Reports Sale of Shares to Cover Tax Obligations
SEC Form 4 Filing
Laura A. Williams, Chief Medical Officer of Ardelvx, Inc., sold 6,421 shares of common stock on May 20, 2025, to cover withholding taxes related to the vesting of restricted stock units.
Summary
- On May 20, 2025, Laura A. Williams, the Chief Medical Officer of Ardelvx, Inc., sold 6,421 shares of the company's common stock.
- The sale was executed at a price of $4.0814 per share.
- This transaction was conducted to cover applicable withholding taxes associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Williams directly owns 402,583 shares of Ardelvx, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting a routine stock sale to cover tax obligations. It doesn't convey any strong positive or negative sentiment regarding the company's performance or future prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of the executive's sentiment towards the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of stock sale transaction. |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, ARDX, Ardelvx, Inc., Laura A. Williams, Chief Medical Officer, Stock Sale, Restricted Stock Units, Withholding Taxes, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.